Drugmakers Must Face Fraud Claims In Valsartan MDL

By Lauren Berg · January 29, 2021, 9:06 PM EST

A New Jersey federal judge said Friday he won't toss fraud claims against drug manufacturers, but will toss the claims against wholesalers and pharmacies, in multidistrict litigation alleging they took part...

To view the full article, register now.

Documents

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

1:19-md-02875

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019